A patient with chronic hypertension presents with left ventricular hypertrophy and elevated serum creatinine levels. Despite adherence to medication, the patient's blood pressure remains high. Which nursing intervention is most appropriate to address this situation?

B) Educate the patient on the importance of adhering to a low-sodium diet.

A) Advise the patient to increase the intake of potassium-rich foods.

B) Educate the patient on the importance of adhering to a low-sodium diet.

C) Recommend the addition of a diuretic to the current medication regimen.

D) Suggest the patient to engage in high-intensity interval training.

A patient with hypertension presents with elevated serum creatinine, high LDL cholesterol, low HDL cholesterol, and ECG findings of left ventricular hypertrophy. The healthcare team is considering adding a new medication to the patient's treatment regimen. Which of the following medications would be most appropriate to address the patient's cardiovascular risks and organ involvement?

A) Angiotensin-converting enzyme (ACE) inhibitor

A patient with newly diagnosed renal artery stenosis is experiencing dizziness and fatigue after starting a calcium channel blocker for hypertension management. What is the most appropriate nursing intervention to address these symptoms while considering the patient's current condition?

B) Educate the patient to change positions slowly to prevent dizziness and monitor the symptoms closely.

A) Discontinue the calcium channel blocker immediately and notify the healthcare provider.

B) Educate the patient to change positions slowly to prevent dizziness and monitor the symptoms closely.

C) Encourage the patient to increase fluid intake to counteract the dizziness caused by the medication.

D) Suggest the patient skip the dose of the calcium channel blocker whenever dizziness occurs.

A patient with a history of hypertension and renal artery stenosis is experiencing dizziness and fatigue after starting a calcium channel blocker. Which nursing intervention is most appropriate to address these symptoms while considering the patient's overall condition?

C) Monitor the patient's blood pressure in different positions to assess for orthostatic hypotension.

A) Instruct the patient to take the medication with food to reduce dizziness.

B) Recommend the patient to lie down immediately after taking the medication.

C) Monitor the patient's blood pressure in different positions to assess for orthostatic hypotension.

D) Advise the patient to increase fluid intake to prevent dehydration.

A week after undergoing renal artery angioplasty, a patient reports experiencing occasional palpitations and mild ankle swelling. The healthcare team is considering adjusting the antihypertensive regimen. Which action should the nurse anticipate to address these symptoms while considering the patient's current condition?

C) Initiate a beta-blocker and monitor for improvement in symptoms.

A) Increase the dosage of the current calcium channel blocker.

B) Switch to an angiotensin-converting enzyme (ACE) inhibitor.

C) Initiate a beta-blocker and monitor for improvement in symptoms.

D) Recommend diuretic therapy to reduce peripheral edema.

A patient who recently underwent renal artery angioplasty presents with occasional palpitations and mild ankle swelling after a recent adjustment in antihypertensive medication. Considering these symptoms and the need to modify the antihypertensive regimen, which medication change would be most appropriate to address the patient's symptoms while managing their hypertension effectively?

B) Switch to an ACE inhibitor while monitoring renal function closely.

A) Increase the dose of the current calcium channel blocker.

B) Switch to an ACE inhibitor while monitoring renal function closely.

C) Add a thiazide diuretic to the current regimen.

D) Initiate a beta-blocker and discontinue the calcium channel blocker.

A patient with hypertension and dyslipidemia has recently started on statin therapy and a modified antihypertensive regimen. The patient reports reduced palpitations and increased energy but has persistent mild ankle swelling. Which nursing intervention is most appropriate to address the patient's current condition?

B) Educate the patient on the importance of daily weight monitoring and report any significant changes.

A) Encourage the patient to increase fluid intake to alleviate the swelling.

B) Educate the patient on the importance of daily weight monitoring and report any significant changes.

C) Advise the patient to avoid exercise until the swelling subsides.

D) Suggest the patient reduce salt intake significantly to manage blood pressure.

A patient who started on a statin and antihypertensive regimen two weeks ago now presents with persistent mild ankle swelling despite improvements in lipid profile and blood pressure. Which nursing intervention is most appropriate to address the patient's current symptom of edema?

C) Advise the patient to elevate the legs periodically throughout the day.

A) Encourage increased fluid intake to flush out excess fluids.

B) Reinforce the importance of adhering to a low-sodium diet.

C) Advise the patient to elevate the legs periodically throughout the day.

D) Schedule daily weights to monitor for fluid retention.

A patient on low-dose diuretic therapy for hypertension presents with occasional dizziness upon standing and a serum potassium level of 3.2 mEq/L. Which nursing intervention is most appropriate to address the patient's symptoms and laboratory findings?

B) Educate the patient on the importance of consuming potassium-rich foods.

A) Encourage the patient to increase fluid intake to manage dizziness.

B) Educate the patient on the importance of consuming potassium-rich foods.

C) Advise the patient to immediately stop taking the diuretic medication.

D) Suggest the patient monitor blood pressure daily and report any low readings.

A patient on low-dose diuretic therapy for hypertension presents with occasional dizziness when standing, a blood pressure decrease from sitting to standing, and mild hypokalemia. Which nursing intervention should be prioritized to address the patient's symptoms and lab findings?

B) Recommend the patient to consume foods high in potassium.

A) Advise the patient to increase fluid intake to manage dizziness.

B) Recommend the patient to consume foods high in potassium.

C) Instruct the patient to wear compression stockings to improve circulation.

D) Encourage the patient to engage in more frequent physical activity.

hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased Peripheral Resistance - Hypertension commonly results from narrowed or constricted blood vessels, increasing the resistance the heart must overcome to pump blood, leading to elevated blood pressure. This can be due to factors like endothelial dysfunction or increased sympathetic nervous system activity.

• Secondary mechanism: Renin-Angiotensin-Aldosterone System (RAAS) Activation - Overactivity of the RAAS leads to vasoconstriction and sodium retention, increasing blood volume and pressure. Angiotensin II causes blood vessels to constrict, while aldosterone prompts the kidneys to retain sodium and water, further elevating blood pressure.

• Key complication: Organ Damage - Chronic hypertension damages organs such as the heart, kidneys, and brain. This damage can lead to complications like heart failure, kidney disease, and stroke, emphasizing the importance of managing blood pressure effectively.

Patient Profile

Demographics:

54-year-old male, office manager

History:

• Key past medical history: Hypertension diagnosed 5 years ago, family history of cardiovascular disease

• Current medications: Lisinopril 20 mg daily, Hydrochlorothiazide 25 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and occasional dizziness

• Key symptoms: Fatigue, blurred vision, mild chest discomfort

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

In the course of continued evaluation, the patient undergoes a comprehensive initial assessment to determine the extent of hypertension's impact on his organs. Laboratory results reveal elevated serum creatinine levels at 1.6 mg/dL, with a normal range being 0.6-1.2 mg/dL, indicating the early onset of renal impairment. Additionally, the patient's lipid profile shows high LDL cholesterol at 150 mg/dL and low HDL cholesterol at 35 mg/dL, which may contribute to the development of atherosclerosis and further cardiovascular risk. An electrocardiogram (ECG) is performed, revealing left ventricular hypertrophy (LVH), a sign of chronic high blood pressure leading to increased cardiac workload.

The persistence of elevated blood pressure, despite adherence to medication, raises concerns about the effectiveness of the current antihypertensive regimen. This necessitates a review and possible adjustment of the treatment plan. The presence of LVH and renal impairment suggests the need for more aggressive blood pressure control and further investigation into potential secondary causes of hypertension, such as hyperaldosteronism or renal artery stenosis. A referral to a nephrologist and a cardiologist may be warranted to explore these possibilities and to prevent further organ damage.

Given these findings, the healthcare team must consider the addition of a calcium channel blocker or a beta-blocker to the patient's regimen to achieve better blood pressure control. Dietary modifications and lifestyle changes, such as a low-sodium diet and regular physical activity, are also emphasized to reduce cardiovascular risk. Close monitoring of renal function and cardiac status is essential to assess the response to these interventions and to adjust the treatment plan accordingly. This approach underscores the importance of a comprehensive management strategy to prevent the progression of hypertensive complications.

Section 2

Following the initial assessment, the healthcare team decides to implement the new treatment plan, which includes the addition of a calcium channel blocker to the patient's antihypertensive regimen. The patient is also educated about the importance of adhering to a low-sodium diet and engaging in regular physical activity. Over the next two weeks, the patient is closely monitored for changes in blood pressure, renal function, and cardiac status. During a follow-up appointment, the patient's blood pressure shows some improvement, averaging 138/88 mmHg, down from 150/95 mmHg at the previous visit. However, the patient reports experiencing occasional episodes of dizziness and fatigue, particularly after taking the new medication.

A repeat laboratory evaluation reveals that the serum creatinine level has slightly increased to 1.8 mg/dL, indicating a potential worsening of renal function. The lipid profile remains unchanged, with LDL cholesterol at 150 mg/dL and HDL cholesterol at 35 mg/dL. The healthcare team suspects that the dizziness may be related to the blood pressure medication, prompting a reevaluation of the dosage and the overall management strategy. Additionally, the patient undergoes a renal ultrasound to assess for possible secondary causes of hypertension, such as renal artery stenosis, which could be contributing to the renal impairment and resistant hypertension.

The ultrasound results reveal evidence of renal artery stenosis, characterized by a significant narrowing of the right renal artery. This finding provides a potential explanation for the patient's resistant hypertension and declining renal function. The healthcare team discusses these results with the patient and considers the possibility of an interventional procedure, such as renal artery angioplasty, to address the stenosis. Meanwhile, the patient's medication regimen is carefully adjusted to balance effective blood pressure control with the preservation of renal function. This development highlights the need for ongoing assessment and tailored interventions to manage the complexities of hypertension and its complications effectively.

Section 3

Following the discovery of renal artery stenosis, the healthcare team decides to proceed with renal artery angioplasty to restore adequate blood flow to the kidneys and improve the patient's blood pressure control. The patient is scheduled for the procedure, and in the meantime, the antihypertensive regimen is adjusted by reducing the dosage of the calcium channel blocker to alleviate symptoms of dizziness and fatigue. The patient is advised to monitor blood pressure at home twice daily and report any significant fluctuations. The team also reinforces dietary modifications, emphasizing the importance of a low-sodium diet to further support blood pressure management.

A week post-angioplasty, the patient returns for a follow-up appointment. The vital signs show a blood pressure of 132/84 mmHg, with the patient reporting a noticeable decrease in dizziness and fatigue. However, the patient mentions experiencing occasional palpitations and mild ankle swelling. A physical examination reveals mild peripheral edema, while cardiac auscultation is unremarkable. The laboratory tests indicate a serum creatinine level of 1.5 mg/dL, suggesting a slight improvement in renal function post-procedure. However, the lipid profile remains a concern, with LDL cholesterol at 148 mg/dL and HDL at 34 mg/dL.

These developments prompt the healthcare team to consider the possibility that the palpitations and edema could be side effects of the current medication regimen, particularly given the recent changes. Therefore, they decide to explore alternative antihypertensive options that might better suit the patient's evolving condition. Additionally, the team plans to initiate a statin therapy to address hyperlipidemia, aiming to reduce cardiovascular risk factors. The patient is scheduled for another follow-up in two weeks to assess the effectiveness of the revised treatment plan and monitor for any new symptoms, ensuring a comprehensive approach to managing hypertension and its associated complications.

Section 4

Two weeks after the initiation of statin therapy and modification of the antihypertensive regimen, the patient returns for a follow-up. During this visit, the patient reports a significant reduction in palpitations, though mild ankle swelling persists. The patient describes an increase in energy levels, allowing for more regular physical activity, which aligns with the healthcare team's emphasis on lifestyle modifications. The vital signs are encouraging, with a blood pressure of 128/80 mmHg and a heart rate of 76 beats per minute, suggesting that the adjusted medication regimen is effectively managing the patient's blood pressure.

Laboratory results reveal a notable improvement in the lipid profile, with LDL cholesterol reduced to 120 mg/dL and HDL cholesterol increased to 42 mg/dL, indicating a positive response to the statin therapy. Additionally, serum creatinine levels have stabilized at 1.4 mg/dL, reflecting continued improvement in renal function. While these results are promising, the persistent peripheral edema prompts the healthcare team to reassess the patient's fluid status and review the possibility of diuretic therapy to alleviate the swelling.

The healthcare team decides to implement a low-dose diuretic as an adjunct to the current regimen, aiming to reduce edema without compromising blood pressure control. The patient is advised to maintain regular blood pressure monitoring and report any new or worsening symptoms promptly. The team schedules another follow-up in four weeks to evaluate the impact of these interventions, monitor potential diuretic side effects such as electrolyte imbalances, and ensure that the patient's overall cardiovascular risk continues to decrease. This approach highlights the importance of ongoing assessment and adjustment in managing hypertension and its related complications.

Section 5

Four weeks later, the patient returns for a scheduled follow-up appointment. During the initial assessment, the nurse notes that the patient has continued to engage in regular physical activity and adheres to dietary recommendations. However, the patient reports experiencing occasional dizziness, particularly when standing up quickly, which raises concerns about potential orthostatic hypotension. The vital signs reveal a blood pressure of 118/76 mmHg while sitting and 100/60 mmHg upon standing, alongside a heart rate of 72 beats per minute. The ankle swelling has decreased significantly, suggesting that the low-dose diuretic has been effective in managing the edema.

Laboratory results show mild hypokalemia with a serum potassium level of 3.2 mEq/L, likely related to the diuretic therapy. Electrolyte monitoring becomes a priority, and the healthcare team considers the addition of a potassium supplement to mitigate this side effect. The patient’s renal function remains stable, with serum creatinine at 1.3 mg/dL, which is reassuring given the adjustments to the medication regimen. The lipid profile continues to improve, with LDL cholesterol reduced further to 110 mg/dL and HDL cholesterol increased to 45 mg/dL.

The healthcare team discusses the importance of monitoring for orthostatic changes and advises the patient on strategies to minimize dizziness, such as rising slowly from sitting or lying positions. They reinforce the necessity of reporting any episodes of severe dizziness or palpitations. The team plans to reassess the patient's medication regimen, particularly the diuretic dosage, to balance effective blood pressure control with minimizing adverse effects. The patient is scheduled for another follow-up in six weeks to evaluate the impact of these interventions and ensure ongoing cardiovascular risk reduction.